Atara Biotherapeutics (ATRA) Change in Taxes (2013 - 2014)
Atara Biotherapeutics (ATRA) reported Change in Taxes of -$62000.0 for Q4 2014, down 145.26% on a YoY basis from $137000.0 in Q4 2013, and up 32.61% quarter-over-quarter from -$92000.0 in Q1 2014.
Atara Biotherapeutics (ATRA) Change in Taxes (2013 - 2014) Analysis & Trends
Atara Biotherapeutics has reported Change in Taxes for 2 years, with the latest figure at -$62000.0 in Q4 2014.
- For the quarter ending Q4 2014, Change in Taxes fell 145.26% year-over-year to -$62000.0; the trailing twelve-month figure through Dec 2014 stood at -$154000.0 (changed N/A YoY), and the FY2014 full-year result was -$154000.0, down 204.05% from the prior year.
- Change in Taxes for Q4 2014 stood at -$62000.0, up from -$92000.0 in the prior quarter.
- The five-year high for Change in Taxes was $137000.0 in Q4 2013, with the low at -$92000.0 in Q1 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Atara Biotherapeutics | 134.61 Mn | 126.21 Mn | 392,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | -62,000.00 |
| Dec 31, 2014 | -62,000.00 |
| Mar 31, 2014 | -92,000.00 |
| Mar 31, 2014 | -92,000.00 |
| Dec 31, 2013 | 137,000.00 |
| Dec 31, 2013 | 137,000.00 |